Review
Open access
Aug 2026
Lipoprotein(a) in cardiovascular disease: pathophysiology, residual risk, and emerging therapeutic strategies
This narrative review summarizes the molecular biology, genetics, epidemiology, pathophysiological mechanisms, and clinical relevance of Lp(a), and critically examines current and emerging therapeutic strategies aimed at reducing Lp(a)-mediated cardiovascular risk.
L. Granata, Simona Giubilato, Francesca Campanella et al.
· Frontiers in Medicine · 0 citations